93 related articles for article (PubMed ID: 2849453)
21. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
22. In vitro tissue potencies of converting enzyme inhibitors. Prodrug activation by kidney esterase.
Grima M; Welsch C; Michel B; Barthelmebs M; Imbs JL
Hypertension; 1991 Apr; 17(4):492-6. PubMed ID: 2013476
[TBL] [Abstract][Full Text] [Related]
23. [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Meyer-Lehnert H; Jahnecke C; Kappes-Horn K; Kramer HJ
Klin Wochenschr; 1991; 69 Suppl 24():45-9. PubMed ID: 1650862
[TBL] [Abstract][Full Text] [Related]
24. Cis-trans isomerization of an angiotensin I-converting enzyme inhibitor. An enzyme kinetic and nuclear magnetic resonance study.
Skoglöf A; Nilsson I; Gustafsson S; Deinum J; Göthe PO
Biochim Biophys Acta; 1990 Oct; 1041(1):22-30. PubMed ID: 2171661
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
26. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
27. Characterization of angiotensin converting enzyme by [3H]captopril binding.
Strittmatter SM; Snyder SH
Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
[TBL] [Abstract][Full Text] [Related]
28. Effects of one-hour and one-week treatment with ramipril on plasma and renal brush border angiotensin converting enzyme in the rat.
Michel B; Stephan D; Grima M; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1993 Oct; 242(3):237-43. PubMed ID: 8281988
[TBL] [Abstract][Full Text] [Related]
29. Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat.
Michel B; Grima M; Coquard C; Welsch C; Barthelmebs M; Imbs JL
Kidney Int; 1994 Jun; 45(6):1587-92. PubMed ID: 7933806
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril.
van Griensven JM; Schoemaker RC; Cohen AF; Luus HG; Seibert-Grafe M; Röthig HJ
Eur J Clin Pharmacol; 1995; 47(6):513-8. PubMed ID: 7768254
[TBL] [Abstract][Full Text] [Related]
33. Effect of temperature and chloride on steady-state inhibition of angiotensin I-converting enzyme by enalaprilat and ramiprilat.
Skoglof A; Göthe PO; Deinum J
Biochem J; 1990 Dec; 272(2):415-9. PubMed ID: 2176463
[TBL] [Abstract][Full Text] [Related]
34. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
35. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
36. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
37. Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats.
Tabata S; Yamazaki H; Ohtake Y; Hayashi S
Arzneimittelforschung; 1990 Aug; 40(8):865-7. PubMed ID: 2173610
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
39. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
40. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
